HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 316 filers reported holding HALOZYME THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.23 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $240,775 | +5.9% | 6,303 | 0.0% | 0.01% | +12.5% |
| Q2 2023 | $227,349 | -13.2% | 6,303 | -8.1% | 0.01% | -27.3% |
| Q1 2023 | $262,060 | -32.9% | 6,862 | 0.0% | 0.01% | -73.2% |
| Q4 2022 | $390,448 | +35.6% | 6,862 | -5.7% | 0.04% | +192.9% |
| Q3 2022 | $288,000 | -10.0% | 7,274 | 0.0% | 0.01% | 0.0% |
| Q2 2022 | $320,000 | +10.3% | 7,274 | 0.0% | 0.01% | +27.3% |
| Q1 2022 | $290,000 | -0.7% | 7,274 | 0.0% | 0.01% | +10.0% |
| Q4 2021 | $292,000 | -1.4% | 7,274 | 0.0% | 0.01% | -16.7% |
| Q3 2021 | $296,000 | -10.3% | 7,274 | 0.0% | 0.01% | 0.0% |
| Q2 2021 | $330,000 | +8.9% | 7,274 | 0.0% | 0.01% | +9.1% |
| Q1 2021 | $303,000 | -2.6% | 7,274 | 0.0% | 0.01% | -21.4% |
| Q4 2020 | $311,000 | – | 7,274 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRAN CAPITAL MANAGEMENT, L.P. | 1,084,118 | $61,686,285 | 7.80% |
| SNYDER CAPITAL MANAGEMENT L P | 3,983,814 | $226,679,017 | 5.12% |
| First Light Asset Management, LLC | 923,119 | $52,525,471 | 4.88% |
| Redwood Investments, LLC | 441,809 | $25,138,932 | 3.37% |
| BERNZOTT CAPITAL ADVISORS | 444,728 | $25,305,023 | 3.27% |
| DOHENY ASSET MANAGEMENT /CA | 46,050 | $2,620 | 3.04% |
| Crawford Lake Capital Management, LLC | 42,171 | $2,399,530 | 2.75% |
| 2Xideas AG | 416,586 | $23,703,743 | 2.51% |
| Granite Investment Partners, LLC | 902,882 | $51,373,986 | 2.14% |
| HighMark Wealth Management LLC | 41,790 | $2,377,851 | 1.79% |